Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTCA.L Regulatory News (TCA)

  • There is currently no data for TCA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

3 Sep 2013 13:39

RNS Number : 1231N
Terra Capital PLC
03 September 2013
 



TERRA CAPITAL PLC

Interim Results for the six months ended 30 June 2013

 

3 September 2013

 

 

Highlights of the period

 

Balance Sheet

30 June 2013

31 December 2012

(US$'000)

(US$'000)

Net assets

62,811

61,878

Net asset per share (US$)

0.89

0.88

Funds returned to shareholders by tender offer

-

30,808

 

 

Income Statement

30 June 2013

31 December 2012

(US$'000)

(US$'000)

Profit after tax

1,548

282

Earnings per share (US cents)

2.2

0.28

 

 

Business highlights

 

 

· 52.8 % of Net Assets now invested in Equities

 

· 32 Equity positions spread across 23 Countries

 

Enquiries

For more information, please visit www.terracapitalplc.com or contact:

 

Galileo Fund Services Limited (Administrator)

David Parnell

+44 1624 692600

 

Panmure Gordon (UK) Limited (Nominated adviser and corporate broker)

Paul Fincham or Jonathan Becher

+44 20 3206 7000

 

Terra Capital plc.

Ian Dungate, Director

+44 1624 692600

Chairman's Statement

The first half of 2013 has seen our new Investment Manager able to concentrate on the business of investing our Company's financial resources in accordance with the investment mandate adopted in 2012.

 

2012 saw a lot of activity which included; finalisation of the disposal of the company's historic real estate assets, the appointment of a new Investment Manager and the adoption of a new investment policy, following on from this the Investment Manager spent a considerable amount of time establishing the necessary custody and brokerage accounts to enable them to implement our new investment policy.

 

The only historic matter outstanding from the previous incarnation of Terra Capital plc is the finalisation and settlement of the tax bill arising on disposal of the AIA Tower. We expect this to be concluded before the end of 2013 but this is dependent on the issuance of a final tax assessment by the authorities in Macau and we are confident that we have reserved sufficient amounts to pay all taxes and there should not be any surprises when we pay the final bill.

 

The Investment Manager has continued its search for undervalued assets in which to invest following the implementation of the investment policy and during the first six months of the year, and as at 30 June our investment portfolio represented 53% of net assets and is invested in 32 diverse positions spread across 23 countries. The separate report of the Investment Manager, which forms part of this interim report, sets out the positions held and the attendant risks and opportunities of a few of them in more detail, Further details on each investment can be found on the Company's website http://terracapitalplc.com/ under News and Reporting "Company Reports".

 

 

Sincerely yours,

Dirk Van den Broeck

 

Chairman

 

Report of the Investment Manager

The Fund's portfolio continued to increase its equity exposure in the 2nd quarter and at the end of the quarter the portfolio was over 52% invested. The Fund increased its exposure to 11 positions held at the end of the 1st quarter, and decreased 4 positions (see accompanying table). At 27.87%, Europe was the Fund's largest geographic exposure as we continued to identify highly compelling valuations across the region. Asia is the second largest regional exposure at 10.93% of the portfolio, with Vietnam and Bangladesh accounting for half that exposure. The Fund pared back its second largest position (as of Q1), Equity Bank of Kenya, as the inflow of foreign money continued to propel the Kenyan market towards its 2007 high. Although Equity Bank's valuation remains reasonable, the influx of foreign capital creates a much higher volatility profile as a Kenyan domestic or global crisis could potentially reverse the flows and severely impact the price. Finally, IRSA, the Fund's Argentine REIT position, dropped sharply in sympathy with June's correction in the emerging markets, but with no significant local or company news. The Fund took the opportunity to increase the position by almost 50% and enjoyed its subsequent recovery. As of July 31, the fund's portfolio looks as follows:

 

 

Region

Country

Security

Quantity

Market value

% of Fund

Share Holdings from Prior Quarter

Europe

Hungary

EGIS RT

18,507

1,752,337

2.81%

Increase

Greece

Eurobank Properties

187,270

1,721,346

2.76%

Increase

France

Ste de la Tour Eiffel

27,114

1,592,926

2.55%

Increase

Switzerland

U-Blox

21,904

1,425,046

2.28%

No Change

Germany

Prime Office

253,279

1,205,321

1.93%

Increase

Russia

JSC ACRON

308,792

1,191,937

1.91%

New

Hungary

Any Security Printing Co.

553,679

1,132,198

1.81%

Increase

Croatia

Hrvatski Telekom

36,228

1,123,073

1.80%

No Change

Montenegro

Crnogorski Telekom

242,624

1,107,166

1.77%

No Change

Macedonia

Komercijalna Banka AD Skopje

22,845

972,613

1.56%

No Change

Portugal

Portucell

305,923

971,229

1.56%

Decrease

Germany

Vib Vermoegen

74,979

938,473

1.50%

Increase

France

Ciments Francais

15,620

915,626

1.47%

New

Estonia

Silvano Fashion Group

267,000

894,654

1.43%

No Change

Serbia

Galenika-Fitofarmacija

8,302

294,576

0.47%

New

Poland

KHGM Polska Miedz

4,390

157,362

0.25%

Decrease

27.87%

Asia

Australia

Ardent Leisure Group

807,977

1,281,471

2.05%

Increase

Georgia

Bank of Georgia Holdings

40,800

1,019,142

1.63%

Decrease

Bangladesh

Brac Bank Ltd

2,436,275

943,114

1.51%

No Change

Bangladesh

Square Pharma

314,040

898,641

1.44%

Increase

Vietnam

Imexpharm Pharmaceutical

534,772

880,345

1.41%

No Change

Vietnam

Hung Vuong Corporation

481,000

846,750

1.36%

New

China

Qingling Motors

3,176,000

781,903

1.25%

New

Vietnam

Hau Giang Pharmaceutical

41,890

174,392

0.28%

Increase

10.93%

Middle East

Oman

Oman Cement

720,950

1,366,996

2.19%

No Change

Qatar

Al Khaliji Bank

273,078

1,248,626

2.00%

No Change

Qatar

Masraf Al Rayan

135,000

1,026,940

1.64%

New

Oman

Oman Refreshment

175,000

1,005,909

1.61%

No Change

7.45%

Africa

Kenya

Equity Bank

4,162,700

1,523,823

2.44%

Decrease

Kenya

Housing Finance Kenya

3,615,500

1,060,910

1.70%

Increase

4.14%

Americas

Argentina

IRSA Inversiones

147,465

1,097,139

1.76%

Increase

Jamaica

Scotia Group Jamaica

1,955,661

411,615

0.66%

New

2.42%

Total Equity Exposure

52.80%

 

 

 

New Positions

 

Six new positions were added to the portfolio in the 2nd quarter, 4 of which the Fund has finished acquiring and are discussed below. Additionally, four positions in the Fund at the end of the 1st quarter were still in the process of acquisition and now that we have reached our desired allocation we can present them to shareholders.

 

VIB Vermoegen

 

Company Description: VIB Vermögen AG is a real estate holding company focusing on commercial properties in southern Germany. The Company acquired the majority of its portfolio from others and developed the rest. VIB has a very diversified portfolio which includes logistics properties, industrial real estate, shopping centres and retail parks, as well as commercial, service and office centres.

 

Investment Rationale: VIB appears to be a low risk investment. It's portfolio of diversified commercial German real estate is concentrated in the most economically robust area of Germany while trading at a 20% discount to book and giving a relatively high Euro dividend yield. VIB's properties have a nearly 98% occupancy rate, an average lease period of over 6 years, and are leased by a very diverse group of companies ranging from BMW and Continental to smaller, yet long-established Mittelstadt companies. The company's operating income grew 14% in the past year, EBIT increased 29.3%, average rental yields increased to 7.5%, FFO rose 16%, and the FFO per fully diluted share is 9.8% (FFO/NAV yield of 7.8%). The 2012 dividend pay-out (distributed in 2013) increased 14% resulting in a current yield of 4.3%. Although VIB's yield is not as high as other companies in the Fund's portfolio, its strong portfolio, discounted price, history of earnings growth and increasing dividends provides strong diversification to the overall portfolio and reliable income.

 

Potential Risks:

 

German Property Prices: Upward revaluation of VIB's portfolio over the past several years has been minimal, with the appraisers applying a conservative discounted cash flow method. However, conservative valuations will not insulate VIB from a general property price decline in Germany if that occurs.

 

Leverage: VIB is fairly leveraged at 2.89x with an average interest rate on its outstanding debt of 4.1%. A material increase in interest rates would not only negatively affect VIB as a yielding security, but could introduce increased refinancing risk.

 

Ardent Leisure Group

 

Company Description: Ardent Leisure is an Australian-based company which owns and operates a leisure portfolio of over 100 assets across Australia, New Zealand and the United States. Its portfolio is grouped into 5 operating groups: theme parks (consisting of 3 parks in Gold Coast, Queensland, Australia), health clubs (operated via the Goodlife Health Club franchise with 40 clubs around Australia), Australian bowling (AMF Bowling Centers, Kingpin Bowling Lounges), Main Event (US-based bowling chain), and marinas (with 7 marinas, the largest group in Australia).

 

Investment Rationale: Ardent Leisure, formerly Macquarie Leisure Trust, is a defensive (47% debt-equity), well-managed leisure/entertainment business with a number of potential opportunities to generate profit growth. It has managed to navigate through a number of difficult challenges, including exceptionally bad weather and a general slump in consumer spending in Australia, to offer an above average yield (8.4%), and solid profit growth of 8-9% from its 2009 nadir. Its main growth has come from health clubs, which it buys at prices significantly lower than its own P/E, and entertainment centres in the United States, which it has been profitably developing in Texas. Although the theme park is somewhat stagnant, Ardent has engaged in several measures to turn it around, including obtaining the exclusive Australian licensing for the Dreamworks' characters.

 

Potential Risks:

Weather: Since the theme parks normally drive nearly 50% of annual EBITDA, the extreme weather Queensland has experienced over the past 5 years can create very significant earnings volatility.

 

Strong/weak Australian dollar: Foreign visitors comprise a material part of the theme park business, and a strong A$ may negatively impact this group. Furthermore, Main Event's US$ earnings would be negatively impacted in A$ terms. Conversely, if the A$ weakens, the stock price, translated into US$, would decline despite the (hopefully) longer term increase in operating profits in A$.

 

Theme-Park Competition: Ardent's primary competitor in the theme-park space, Village Roadshows, which operates in conjunction with Warner Brothers, is investing heavily in its parks and may take market share from Ardent's theme parks.

 

Health Club Consolidation: The health club business requires Ardent to continue to acquire clubs cheaply and successfully migrate them into its Goodlife platform.

 

U.S. Expansion: While Ardent's U.S. leisure segment is a high growth area, it depends on management getting the correct location and marketing.

 

Acron Group:

 

Company Description: Acron is a Russian-domiciled fertilizer manufacturer with the majority of production located in Russia, but which sells its products globally The company specializes in the sale of NPK, a more complex form of fertilizer, and is the second largest company producer of NPK in the world. Acron owns 3% of Uralkali, a $21 billion Russian potassium miner and potash manufacturer.

 

Investment Rationale: Acron trades at a lower price-to-earnings ratio (4.5 as of June 30 and 1Q trailing 12-month earnings) than any other company in the industry, trades at a significant discount to book value (0.8 of book), and generates a generous dividend yield (8.67% based on June 30 price and 2Q trailing 12-month dividend payments). Acron is currently implementing a major expansion plan to transform itself into a fully integrated fertilizer manufacturer with interests in raw material mining (i.e. potash and apatite), and the manufacture of urea. The expansion be will partially funded by increasing debt from around 2x EBITDA to approximately 3x EBITDA, as well as selling its interest in Uralkali. This has raised the company's debt-equity levels to 122% (based on 1Q financials), which is one of the highest in the industry. The expansion plan, after careful analysis, appears reasonable and should be value accretive, and the expected sale of Uralkali, at almost 3x book value, would facilitate investments in essentially the same line of business while the company itself trades at 0.8x book. The debt levels seem to be the principal reason, along with generally negative sentiment towards Russian companies, for Acron's current valuation.

 

Despite the concentration of the company's ownership (80%) with one individual, Vyaechslav Kantor, the management team has a demonstrable long-term record of solid investment in building the company, is extremely open about its financials, provides timely and through information to analysts, has consistently adequately announced major strategic decisions and explained them to investors, scores well on almost any corporate governance metric, and has demonstrated respect for minority shareholders through strong cash dividends.

 

Potential Risks

 

Fertilizer Prices: There are several risks in regard to the price of fertilizer: First, prices are currently above their long-term average, but less than half their peak in 2008. A further reversion to the long-term average would materially impact Acron's earnings. Second, fertilizer prices are highly sensitive to, and driven by, grain prices. Any weakening in grain prices would indicate weakening fertilizer prices. Third, China restricts exports, leading to a lower than normal price in China. Should this policy change, global fertilizer prices will almost certainly decline. Finally, many countries subsidize fertilizer imports, the most important of these being India. Any reduction in these subsidies would negatively impact global fertilizer prices.

 

Leverage: Acron has opted to significantly increase leverage in a period when ample global liquidity provides a strong incentive to do so; however, the leverage has been used mainly to invest in production and mining facilities that would allow Acron to compete as a full service supplier of Fertilizer. Clearly, a reversal of global financial conditions and a concurrent decline in global fertilizer prices could create significant financial stress.

 

Russia as a country: Several of the reasons for the current low valuations for Russian companies include the historically poor levels of corporate governance, omnipresent oligarchs, and state interference in various companies.

 

Uralkali: As Uralkali equity holdings represent approximately 40% of Acron's equity, a material decline in Uralkali's share price would directly impair Acron's net asset value.

 

Ciments Francais S.A.:

 

Company Description: Ciments Francais is a French cement manufacturer, which in turn is a majority owned subsidiary of Italcementi, the fifth Largest cement producer in the world. Ciments Francais produces cement in France (where it is the 2nd largest producer) and Belgium (3rd largest), with significant subsidiaries in Egypt (Suez Cement), Morocco (Ciments du Maroc), India and Thailand, and minor subsidiaries in Spain, Bulgaria, Greece, Kazakhstan, U.S. and Canada.

 

Investment Rationale: The markets in which Ciments Francais operates, apart from India and Thailand, have either been plagued by recession (Europe), political crises (Egypt), or government intervention (Morocco), and the market responded by assigning it a low valuation. The company's decision to write off significant goodwill has had a marked negative short-term effect on earnings, but has cleansed much of the legacy of previous acquisitions. Investors' uncertainty over Ciments Francais has resulted in it trading at half post-write off book value and less than 3x cash flow, giving it a dividend yield of nearly 8.5%, a P/E of about 6 (after adding back amortization costs), with lower leverage (93% debt-equity; 75% net of cash) and a higher ROA than the major companies in the industry. Essentially, the Fund is buying a company at the bottom of its industry cycle, operating in numerous problematic markets. We believe that the market has overpriced these risks, creating an intriguing entry point at the prices we bought this positon.

 

Potential Risks

 

Construction Spending in Europe: The company projects that cement deliveries will decline several percentage points, but Holcim and Lafarge have closed smaller plants in France, which has eased some of the overcapacity issue. However, Europe's stagnation the past 5 years may very well continue or deteriorate further, reducing demand for cement.

 

Morocco:Morocco has both cut subsidies for public housing and imposed additional taxes on the cement industry. The government's budget process has proven erratic, both in the spending and tax side, and this uncertainty adds to the market's risk analysis of Ciments Francais.

 

Egypt: Beyond the obvious political turmoil enveloping the country, Ciments Francais' Egypt production is based on a non-standard diesel (mazut) that has been heavily dependent on government subsidies. The government intends to remove the subsidies to the point where the fuel trades at the global price, but how fast they remove them has been the subject of often tense negotiations.

 

Square Pharmaceuticals Limited

 

Company Description: Square Pharmaceutical is the largest pharmaceutical company in Bangladesh (since 1985) with a local market share of around 19% and with 97% of its revenue coming from the local market. Square's production focuses on generics that are not price regulated by the government. Square is currently completing a new facility (expected operational launch in 2014) to increase its production by 22% to over 10 billion tablets and capsules.

 

Investment Rationale: The Bangladeshi bear market entered its third year in 2013. Local and foreign investors exhibited little interest in even the best managed companies and Square's share price fell to valuation levels last seen in 2006 (p/e of 15), despite its annualized earnings growth of 20% since 2000 and 16% over the past 3 years. Square's strong ROE of 18% is even more impressive in light of its minimal levels of leverage (21% debt-equity; 16% debt-equity net of cash). Square has successfully increased its gross, EBIT and net margins the past three years. The company has engaged in large expansion in production capacity which we expect to come online in 2014, substantially driving top and bottom-line growth.

 

At the pharmaceutical industry level, the World Bank estimates Bangladeshi pharmaceutical expenditures per capita was USD $23 per person, among the lowest rates in the world; this is only 11% of the per capita expenditure in China, less than half of that in India, and only about 30% of that in Vietnam. Although the Bangladeshi economy is improving thanks to capital investments in labor intensive industries and large remittance payments, per capita pharmaceutical expenditure is comparable with the world's worst states: it is lower than Yemen, Chad and Rwanda. Industry players project the Bangladeshi market to average over 15% growth for the next 4 years. The combination of a solidly managed, well-respected company in a rapidly growing industry, generating an appealing return on equity, at multi-year lows provided our main justification to invest at a somewhat higher P/E than we normally pay.

Potential Risks

 

Pharmaceutical Spending: Pharmaceutical consumption drivers in Bangladesh are complex and include government spending, the urbanization process, and the constant flow of remittances into the economy. Despite the optimistic projections, pharmaceutical spending in the local market may fall short or even stagnate.

 

Increased Competition: There are over 100 drug companies operating in Bangladesh, and the top 10 account for 68% of the market. Aggressive pricing by Square's competitors to take market share could affect its margins.

 

Bangladeshi Bear Market: Despite its strong financial performance and solid reputation, it does have a high correlation to the general Bangladeshi market and that market has continued to produce volatile declines.

 

Delay in New Production Facility: Square is already operating at over 100% capacity in its capsule production and any further delay in bringing the new facility online (facility was originally slated to begin production in 2013) would materially affect growth projections.

 

Hung Vuong Corporation (HVG Vietnam)

 

Company Description: This is the largest pangasius producer and exporter in Vietnam (since 2008) with 10.3% market share and export value of USD $124 Million in 2011. Hung Vuong relies on an integrated business model to maintain its dominant position in the market. It is the only company in the fishery sector with a fully integrated value chain from fish feed to farming, processing and cold storage, and is able to meet a substantial amount of raw fish inputs through its subsidiaries and related companies. The company currently has 250ha of fish farming area in addition to 100ha in contract with local farmers providing over 150,000 tons of raw fish annually, and 12 fish processing plants with a combined daily processing capacity of 1,700 tons per day. HVG also has a large cold storage facility with a total storage capacity of 42,000 tons in Ho Chi Minh City to ensure a stable supply of raw fish for the company. Pangasius is one of the cheapest white fish in the market and enjoys wide familiarity among end buyers. Due to a favorable natural environment in the Mekong Delta region, which serves as a suitable breeding ground for these species, for years Vietnam has been the largest Pangasius exporter in the world and Vietnamese Pangasius is known for its flavor and nutritional values.

 

Investment Rationale: Hung Vuong derives at least 2/3 of its revenue from export. Market; domestic sales account for a small portion of its profit. This helps shield the Company from Vietnamese country risks. Since its revenue is in USD, deterioration in the value of local currency would help boost its profit margin, a very helpful position with inflation traditionally running at 20% per year. Its strong and reliable supply chain allows the Company to reduce input costs and control product quality to meet even the most stringent product quality standards by European importers. This has helped the Company to sustain its earnings even during the trying periods of reduced demand, such as in 2008. HVG also owns 48% stake of the Hung Vuong Mien Tay JSC that owns a fish farm of 250 ha. It supplies around 150,000 tons of raw fish per annum, fulfilling about 70% of the Company's demand. In addition, HVG also attempted to expand its shrimp production business by the 24% acquisition of FBT from SCIC. FBT has 612ha of shrimp farming area and 100ha of catfish farming area, which means this acquisition would be able to help Hung Vuong to have 100% control over its raw fish material. In an industry that is constantly facing the shortage in raw fish supply, the vertical integration of HVG gives it a competitive edge against its peers.

 

Potential Risks

 

Possible Trade Restrictions: The biggest challenge for Hung Vuong's export growth is the potential imposition of trade restrictions by its major importing countries. Pangasius competes directly with catfish in the international fish markets, being similar in terms of taste and quality. Budget problems in Europe and a reduced domestic catfish farming area in US could reduce the likelihood that substantial support will be given to local farmers in these countries and hence reduce the likelihood that the Company's sales would be significantly adversely impacted.

Raw Material Supply Problems: There is a permanent instability in raw material supply. Some small farmers left farming ponds uncultivated and farming areas of some key provinces are often lost due to floods. Although the Company can control a large part of its raw material supply thanks to ownership of companies at the upper end of the supply chain, instability still affects its ability to maintain a stable profit margin.

 

Qingling Motors Co. Ltd (#1122 Hong Kong Exch.)

 

Company Description: Qingling is a Hong Kong listed Chinese company ("H" Share). The majority of the company is state-owned, but Isuzu, a key shareholder, owns 20%. It manufactures, distributes and sells Isuzu light trucks, pick-up trucks, medium and heavy trucks under license from Isuzu as well as auto parts, importing many parts from Isuzu in Japan. As part of this agreement, Qingling is the recipient of a significant amount of management expertise and technology transfer from Isuzu. It has about a 3% market share of China's light truck market.

 

Investment Rationale: Qingling is trading at a 40% discount of its tangible book value and at only 1.14 times its cash balance, with existing production capacity, some solid market share (3%), and a strong and expanding distribution network. The company's light trucks are widely regarded in China as the best in their class. The company has distributed 80-85% of its net profits as dividends (resulting in a 5.7% yield) and managed to finance its target capital expenditure plan (about 500-600 million RMB a year) with operating cash flow. The specific niche dominated by Qingling is light, high quality commercial vehicles, and the company would therefore benefit from higher domestic consumer spending in China, as well as the introduction of higher environmental emission standards currently being contemplated.

 

Potential Risks

Battle for Market Share: Qingling reduced prices during the recent industry-wide sales decline to capture market share, which was successful. The price war may intensify, further diminishing the company's margins.

 

Slowdown in Implementation of Environmental Regulations: China's push to address its environmental degradation may be stymied by a slowing economy. Delays in implementation of stricter standards would diminish part of the rationale for consumers to pay up for Qingling's premium pricing.

 

Domestic Spending Slowdown: Despite a cut prices and significant brand strength, Qingling was unable to avoid China's nearly universal auto sales decline in 2012.

 

Negative Sentiment Affecting Japanese Products: Although not as obviously Japanese as Toyota or Sony, Qingling is manufacturing, selling and servicing a Japanese truck. Further tensions resulting in Chinese boycotts of Japanese products could impact sales.

 

Masraf Al Rayan

 

Company Description: Masraf is a Qatari bank that takes in deposits and provides commercial and investment banking products in accordance with Islamic principles.

Investment Rationale: The Qatari market is in a cyclical trough, but the bank still managed one of the highest ROEs (16.8%) among Islamic banks and 3 year average annual earnings growth of 16.8%. We believe spreads in Qatar have been held down by the government to prevent more government capital from being routed to the banks, most of which have a majority of depositors and borrowers that are state or parastatal companies. This is to prevent the size of the State (owing to the Gas industry) dominating the Qatari economy; however, we believe that the Qatar government's grand development plans will require more robust bank funding and it will then allow an increase in the spreads on offer. Furthermore, the bank will benefit from the general rise of Islamic banking worldwide, especially since Qatar has become one of the world centers for the certification of Islamic financial products, development of Islamic financing techniques, and specialists to handle large Islamic financial loans.

Potential Risks

 

Expansion of Islamic Banking Model: Masraf has benefited from both the expansion of Islamic banking and Qatar's emergence as a center of such activity. Any curtailment in this growth would directly affect the bank.

 

Government Funnelling Growth Through Banks: The government may opt not to focus on financing the pending infrastructure through the banks or might manage to fund the needed growth while maintaining tight spreads.

 

 

Respectfully submitted,

 

Terra Partners Asset Management Limited

Portomaso Tower Suite 8/5A

Portomaso Ave

St. Julian's Malta STJ4011

Telephone +356-2371-7000

Regulated by Malta Financial Services Authority, Reg No. C56353

 

 

Unaudited consolidated income statement

 

Note

For the period from

1 January 2013 to

30 June 2013

For the period from

1 January 2012 to

30 June 2012

US$'000

US$'000

Income

 

Interest income on cash balances

160

386

Dividend income on quoted equity investments

894

-

Net changes in fair value on financial assets at fair value through profit or loss

1,643

-

Total net income

2,697

386

Manager's fees

6

(882)

(112)

Audit and professional fees

(108)

(62)

Other expenses

(159)

(299)

Administrative and other expenses

(1,149)

(473)

Profit/(loss) before tax

1,548

(87)

Taxation

11

-

-

Profit/(loss) for the period from continuing operations

1,548

(87)

Profit for the period from discontinued operations net of tax

-

369

Profit for the period

1,548

282

Earnings per share (cent per share) for the equity holders of the Company during the period

9

2.20

0.28

 

 

 

Unaudited consolidated statement of comprehensive income

For the period from 1 January 2013 to 30 June 2013

For the period from 1 January 2012 to 30 June 2012

US$'000

US$'000

Profit for the period

1,548

282

Other comprehensive income

Foreign exchange differences

(615)

190

Total comprehensive profit for the period

933

472

 

 

Unaudited consolidated balance sheet

 

Note

Unaudited

At 30 June 2013

Audited

At 31 December 2012

US$'000

US$'000

Financial assets at fair value through profit or loss

7

33,203

13,104

Due from Broker

1,433

1,006

Trade and other receivables

8

465

112

Cash and cash equivalents

39,195

60,292

Total current assets

74,296

74,514

Total assets

74,296

74,514

Issued share capital

10

7,726

7,726

Share premium

62,356

62,356

Retained earnings

(12,353)

(13,901)

Other reserves

5,274

5,274

Foreign currency translation reserve

(192)

423

Total equity

62,811

61,878

Total current liabilities

Taxation

13

10,868

10,837

Trade and other payables

13

617

1,799

Total current liabilities

11,485

12,636

Total liabilities

11,485

12,636

Total equity and liabilities

74,296

74,514

Net Asset Value per share

5

0.89

0.88

 

 

Approved by the Board of Directors on 2 September, 2013

 

 

 

Ian Dungate Filip Montfort

 

Director Director

 

 

Unaudited consolidated statement of changes in equity

for the six months ended 30 June 2013

 

Share capital

Share premium

Retained earnings

Capital redemption reserve

Foreign currency translation reserve

Total

 

 

US$'000

US$'000

US$'000

US$'000

US$'000

US$'000

Balance at 1 January 2013

7,726

62,356

(13,901)

5,274

423

61,878

Profit for the period

-

-

1,548

-

-

1,548

Other comprehensive income

Foreign exchange translation differences

-

-

-

-

(615)

(615)

Total comprehensive profit

-

-

1,548

-

(615)

933

 

Total contributions by and distributions to owners

-

-

-

-

-

-

Balance at 1 January 2013

7,726

62,356

(12,353)

5,274

(192)

62,811

 

for the six months ended 30 June 2012

 

Share capital

Share premium

Retained earnings

Capital redemption reserve

Foreign currency translation reserve

Total

 

 

US$'000

US$'000

US$'000

US$'000

US$'000

US$'000

Balance at 1 January 2012

10,783

62,356

16,593

2,217

56

92,005

Profit for the period

-

-

282

-

-

282

Other comprehensive income

Foreign exchange translation differences

-

-

-

-

190

190

Total comprehensive profit

-

-

282

-

190

472

Shares repurchased to be held in treasury

-

-

(30,834)

-

-

(30,834)

Cancellation of shares repurchased

(3,057)

-

-

3,057

-

-

Total contributions by and distributions to owners

(3,057)

-

(30,834)

3,057

-

(30,834)

 

Balance at 30 June 2012

7,726

62,356

(13,959)

5,274

246

61,643

 

Unaudited consolidated statement of cash flows

For the period from

1 January 2013 to 30 June 2013

For the period from

1 January 2012 to 30 June 2012

US$'000

US$'000

Operating activities

Profit before tax

1,548

282

Adjustments for:

Net changes in fair value on financial assets at fair

(1,643)

-

value through profit or loss

Net gain on disposal of assets held for sale

-

(369)

Finance income

(160)

(386)

Finance costs

6

2

Operating loss before changes in working capital

(249)

(471)

Increase in trade and other receivables

(353)

(198)

(Decrease)/increase in trade and other payables

(1,151)

915

(1,753)

246

Taxation paid

-

-

Net finance costs paid

(6)

(2)

Interest received

160

386

Cash flows (used in)/generated from operating activities

(1,599)

630

Investing activities

Purchase of Financial Assets

(18,456)

-

Funds held at Brokers

(427)

-

Proceeds on sale of investment property due to tax authorities

-

11,506

Disposal of assets held for sale

-

77,558

Cash flows (used in)/generated from investing activities

(18,883)

89,064

Financing activities

Purchase of shares

-

(30,834)

Cash flows used in financing activities

-

(30,834)

Net (decrease)/increase in cash and cash equivalents

(20,482)

58,860

Adjustment for foreign exchange

(615)

190

Cash and cash equivalents at beginning of period

60,292

15,916

Cash and cash equivalents at end of period

39,195

74,966

 

Notes to the consolidated financial statements

1. The Company

 

Terra Capital plc (formerly Speymill Macau Property Company plc) was incorporated and registered in the Isle of Man under the Isle of Man Companies Acts 1931 to 2004 on 31 October 2006 as a public company with registered number 118202C.

 

Pursuant to the Extraordinary General Meeting held on 24 May 2012 a tender offer was made for ordinary shares of US$0.10 each in the issued ordinary share capital of the Company at a price of US$0.835 per ordinary share. As a result of the tender 36,896,674 shares were tendered and were purchased by the Company.

 

The interim consolidated financial statements of Terra Capital plc as at and for the six months ended 30 June 2013 comprise the Company and its subsidiaries (together referred to as the "Group").

 

The consolidated financial statements of the Group as at and for the year ended 31 December 2012 are available upon request from the Company's registered office at Millennium House, 46 Athol Street, Douglas, Isle of Man, IM1 1JB or at www.terracapitalplc.com.

 

The Company's investment objective is to achieve capital appreciation while attempting to reduce risk primarily by applying a disciplined and diversified value investing philosophy.

 

2 Statement of compliance and significant accounting policies

 

These condensed consolidated interim financial statements have been prepared in accordance with IAS 34 Interim Financial Reporting. They do not include all of the information required for full annual financial statements, and should be read in conjunction with the consolidated financial statements of the Group as at and for the year ended 31 December 2012.

 

These condensed consolidated interim financial statements were approved by the Board of Directors on 2 September 2013.

 

The Group has one segment focusing on achieving capital appreciation while attempting reduce risk primarily by applying a disciplined and diversified value investing philosophy. No additional disclosure is included in relation to segment reporting as the Group's activities are limited to one business segment.

 

The Group's financial risk management objectives and policies are consistent with those disclosed in the consolidated financial statements as at and for the year ended 31 December 2012.

 

The accounting policies applied by the Group in these condensed consolidated interim financial statements are the same as those applied by the Group in its consolidated financial statements as at and for the year ended 31 December 2012.

 

3 Use of estimates and judgements

 

The preparation of interim financial statements requires management to make judgements, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets and liabilities, income and expense. Actual results may differ from these estimates.

 

Following the sale of the investment property the only significant area requiring estimation is the finalisation of the tax liability relating to the sale of the property.

 

4 Finance income and costs

 

 

Period ended

30 June 2013

Period ended

30 June 2012

US$'000

US$'000

Bank interest income

160

386

Finance income

160

386

Interest expense

-

Bank charges

(6)

(2)

Finance costs

(6)

(2)

Net finance income

154

384

 

5 Net asset value per share

The net asset value per share as at 30 June 2013 is US$0.89 based on 70,229,236 ordinary shares in issue as at that date (excluding 7,026,423 shares held in treasury) (31 December 2012: US$0.88 based on 70,229,236 ordinary shares).

 

6 Related party transactions

 

Balances and transactions between the Company and its subsidiaries, which are related parties of the Company, have been eliminated on consolidation and are not disclosed in this note. Details of transactions between the Group and other related parties are disclosed below.

 

Parties are considered to be related if one party has the ability to control the other party or to exercise significant influence over the party making financial or operational decisions.

 

Directors of the Company

 

Howard Golden, Filip Montfort and Yarden Mariuma are directors of the Manager. The Manager was appointed at the EGM held on 24 May 2012. Following the EGM Mr Golden and Mr Mariuma resigned as directors of the Company and Mr Dirk van den Broeck was elected Chairman of the Board of Directors as an independent non-executive director and Mr Ian Dungate was elected as an independent director.

 

The Investment Manager was appointed to that position at the EGM held on 24 May 2012, following which Mr Golden and Mr Mariuma (who were board members and also directors of the Investment Manager) resigned as directors of the Company. Mr Dirk van den Broeck was elected Chairman of the Board of Directors as an independent non-executive director and Mr Ian Dungate was elected as an independent non-executive director.

 

Filip Montfort is a director of the Investment Manager and remained as a Director of the Company following the above noted EGM.

 

Mr Dungate is a director and principal of the administrator.

 

With effect from the date of appointment of the Manager, Mr Montfort has agreed to waive his entitlement to Directors remuneration going forward.

 

The Investment Manager

Following the EGM held on 24 May 2012, the Company appointed Terra Partners Asset Management ("TPAM") as its investment manager (the "Manager").

 

Term and termination

The Investment Management Agreement may be terminated by either party giving to the other not less than 12 months' notice expiring on or at any time after the third anniversary of the commencement date of the agreement or otherwise, in circumstances, inter alia, where one of the parties has a receiver appointed over its assets or if an order is made or an effective resolution passed for the winding-up of one of the parties.

Management fee

The Manager shall be entitled to receive a management fee equal to 2 per cent. per annum of the aggregate Net Asset Value of the Company during the relevant fee payment period, calculated on the first day of each month, accrued on a daily basis and payable monthly in arrears (or pro rata for lesser periods).

 

Performance fee

The Manager is also entitled to receive a performance fee equal to 20 per cent. of the increase (if any) in the Net Asset Value per Share (with dividends and other distributions added back and ignoring any accrued performance fee) as at each semi-annual performance fee calculation period above the Net Asset Value as at the commencement of each such semi-annual performance fee calculation period, provided that any performance fee shall be payable only to the extent that the Net Asset Value of the Share exceeds the Net Asset Value immediately following the settlement of the Tender Offer or, if a performance fee has been paid, the Net Asset Value per Share when a performance fee was last paid. The performance fee shall be calculated on 30 June and 31 December in each year and paid following such calculation.

Expenses

In addition, the Company shall be responsible for the payment of all out-of-pocket expenses reasonably incurred by the Manager in the proper performance of the Investment Management Agreement up to a maximum of US$75,000 per annum.

 

The Administrator

The Administrator is entitled to receive a fee of 10 basis points per annum of the net assets of the Company between £0 and £100m and 7.5 basis points of the net asset value of the Company in excess of £100m, subject to a minimum monthly fee of £4,000, and a maximum monthly fee of £11,250 payable quarterly in arrears.

 

The Administrator assists in the preparation of the financial statements of the Company for which it receives a fee of £1,750 per set and provides general secretarial services to the Company for which it receives a minimum annual fee of £5,000.

 

7 Financial assets at fair value through profit or loss

 

Group

30 June 2013: Financial assets at fair value through profit or loss (all quoted equity securities):

 

 

Security name

Number

US$'000

Ardent Leisure Group

807,977

1,266

Brac Bank Ltd

2,436,275

929

Square Pharma

314,040

881

U-Blox Holding AG

21,904

1,414

Ciments Francais

15,620

878

Crnogorski Telekom AD Podgoric

242,624

1,136

Eurobank Properties Real Estate Inv Co

187,270

1,759

Portucel Empresa Produtora

305,923

994

Prime Office REIT

253,279

1,176

Silvano Fashion Group

267,000

913

Tour Eiffel

28,524

1,711

VIB Verboegen

74,979

961

Bank of Georgia Holdings

40,800

1,036

Qingling Motors

3,254,000

810

Hrvatski Telekom

36,228

1,123

Allami Nyomda

553,679

1,124

EGIS Pharmaceuticals plc

18,507

1,786

Scotia Group

1,953,661

412

Equity Bank Ltd

4,162,700

1,519

Housing Finance Co Ltd

3,615,500

1,066

Komercijalna Banka AD

22,845

958

Oman Cement Company

720,950

1,352

Oman Refreshment Company

175,000

1,006

KGHM Polska Miedz

4,390

295

Al Khaleej Bank

273,078

1,267

Masraf Al Rayan

135,000

1,023

Galenika Fitofarmacija

8,302

251

IRSA SP-ADR

147,465

1,096

JSC Acron

308,792

1,192

Hau Giang Pharmaceutical

41,890

172

Hung Vuong Corporation

481,000

837

Imexpharm Pharmaceutical

534,772

860

33,203

 

8 Trade and other receivables

30 June 2013

31 December 2012

US$'000

US$'000

Prepayments and other receivables

465

112

465

112

 

9 Earnings per share

 

Basic earnings per share is calculated by dividing the profit for the period attributable to equity holders of the Company by the weighted-average number of ordinary shares in issue during the period.

 

Period ended

30 June 2013

Period ended

30 June 2012

Profit attributable to equity holders of the Company (US$'000)

1,548

282

Weighted average number of ordinary shares in issue (thousands) (excluding 7,026,423 held in treasury (2012: excluding 36,896,674 shares purchased by tender offer and 35,000 shares purchased in the market during the period of which 30,573,251 were cancelled and 7,026,423 were placed in treasury)

70,229

100,425

Earnings per share (cent per share)

2.20

0.28

 

10 Share capital

30 June 2013

US$'000

31 December 2012

US$'000

Authorised:

400,000,000 Ordinary shares of US$0.10 each

40,000,000

40,000,000

Allotted, Called-up and Fully-Paid:

70,229,236 Ordinary shares of US$0.10 each in issue, with full voting rights

7,023

7,023

7,026,423 Ordinary shares of US$0.10 each in issue, with full voting rights

703

703

7,726

7,726

 

Ordinary shares retained in treasury

 The Ordinary shares held in treasury have no voting rights and are not entitled to dividends.

 

11 Taxation

 

Isle of Man taxation

 

The Company is resident in the Isle of Man for tax purposes and pays income tax at 0%. The Company pays a corporate charge of £250 to the Isle of Man Government for each tax year.

 

Macau taxation

 

The Company's subsidiaries resident in Macau are liable to Macau Complimentary Tax at 12% in respect of their operating profits, excluding rental income which is subject to property tax.

 

12 Directors' remuneration

 

The maximum amount of basic remuneration payable by the Company by way of fees to the Directors permitted under the Articles of Association is £200,000 per annum. All Directors are each entitled to receive reimbursement of any expenses incurred in relation to their appointment.

 

Mr Van den Broeck, as Chairman, is entitled to remuneration of US$45,000 per annum from the date of his appointment and Mr Dungate and Mr Montfort are each entitled to remuneration of US$30,000 per annum. Mr Montfort has agreed to waive his director's fees for so long as he is associated with the Manager.

 

13 Trade and other payables

30 June 2013

31 December 2012

US$'000

US$'000

Taxation payable*

10,867

10,837

Due to broker

-

1,040

Sundry creditors and accruals

618

759

Total

11,485

24,513

 

* Following disposal of the AIA Tower in Macau in 2011 this liability remains outstanding until submission of the 2012 tax return for Macau.

 

14 Contingent liabilities and capital commitments

 

The Company has no outstanding capital commitments at 30 June 2013.

 

 

15 Post balance sheet events

 

On 27 August 2013 the Company received confirmation from the High Court of Justice of the Isle of Man of its approval for the Company to cancel the amount of the share premium account and for such amount to be credited as a distributable reserve. Having received court approval, the amount of the share premium account so cancelled will be credited as a distributable reserve which will be able to be applied in any manner in which the Company's profits available for distribution are able to be applied.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR LXLFBXKFXBBV
Date   Source Headline
28th Mar 20192:30 pmRNSGeneral Meeting result and liquidator appointment
28th Mar 20197:30 amRNSSuspension - Terra Capital Plc
13th Mar 201911:30 amRNSNet Asset Value(s)
27th Feb 20193:00 pmRNS20 Day Delisting Announcement
13th Feb 201911:00 amRNSNet Asset Value(s)
1st Feb 20191:28 pmRNSCompletion of partial compulsory redemption
25th Jan 20197:00 amRNSThird compulsory redemption of shares
17th Jan 20199:26 amRNSNet Asset Value(s)
27th Dec 20183:30 pmRNSHolding(s) in Company
17th Dec 201811:50 amRNSNet Asset Value(s)
16th Nov 201810:00 amRNSNet Asset Value(s)
14th Nov 20181:40 pmRNSResult of AGM
12th Oct 201810:30 amRNSNet Asset Value(s)
10th Oct 20182:18 pmRNSPosting of Interim report and Notice of AGM
4th Oct 20184:00 pmRNSCompletion of partial compulsory redemption
27th Sep 20182:30 pmRNSInterim Resutls
26th Sep 201812:02 pmRNSSecond Compulsory Redemption of Shares
17th Sep 20189:52 amRNSNet Asset Value(s)
15th Aug 20183:30 pmRNSNet Asset Value(s)
6th Aug 20189:30 amRNSCompletion of partial compulsory redemption
20th Jul 20187:00 amRNSCompulsory Redemption of Shares
16th Jul 201812:53 pmRNSNet Asset Value(s)
10th Jul 201811:08 amRNSResults of Extraordinary General Meeting
27th Jun 20185:00 pmRNSPosting of Annual Accounts
27th Jun 20187:00 amRNSAnnual Financial Report
15th Jun 20184:30 pmRNSCircular re: Realisation Opportunity
15th Jun 20184:17 pmRNSNet Asset Value(s)
15th May 20189:30 amRNSNet Asset Value(s)
1st May 20189:00 amRNSFund Manager's update regarding Q1 2018
19th Apr 201812:30 pmRNSUpdate re Realisation Opportunity
16th Apr 20189:00 amRNSNet Asset Value(s)
11th Apr 201812:00 pmRNSNotification of Major Holdings
10th Apr 201812:00 pmRNSNotification of Major Holdings
6th Apr 20184:56 pmRNSNotification of Major Interest in Shares
14th Mar 20182:00 pmRNSNet Asset Value(s)
14th Mar 201812:00 pmRNSNotification of Major Holding
13th Mar 20187:00 amRNSResult of Tender Offer
12th Mar 20187:00 amRNSResult of EGM
1st Mar 201811:25 amRNSFund Manager's update regarding Q4 2017
15th Feb 201812:00 pmRNSTender Offer
13th Feb 20189:31 amRNSNet Asset Value(s)
15th Jan 20189:30 amRNSNet Asset Value(s)
21st Dec 201712:00 pmRNSNotification of Major Holdings
14th Dec 201711:29 amRNSNet Asset Value(s)
14th Nov 20171:00 pmRNSNet Asset Value(s)
2nd Nov 20177:00 amRNSFund Manager's Update Q3 2017
11th Oct 201711:00 amRNSNet Asset Value(s)
3rd Oct 20179:30 amRNSPosting of Interim Report
27th Sep 201710:30 amRNSInterim Results
18th Sep 201710:29 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.